The store will not work correctly when cookies are disabled.
2-(4-bromophenyl)-6-hydroxy-4H-chromen-4-one
ID: ALA5177455
PubChem CID: 86000049
Max Phase: Preclinical
Molecular Formula: C15H9BrO3
Molecular Weight: 317.14
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: O=c1cc(-c2ccc(Br)cc2)oc2ccc(O)cc12
Standard InChI: InChI=1S/C15H9BrO3/c16-10-3-1-9(2-4-10)15-8-13(18)12-7-11(17)5-6-14(12)19-15/h1-8,17H
Standard InChI Key: OVZGCNYKIUXFLR-UHFFFAOYSA-N
Molfile:
RDKit 2D
19 21 0 0 0 0 0 0 0 0999 V2000
-0.3579 -1.8552 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-0.3579 -1.0302 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.3564 -0.6177 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.3564 0.2071 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.0709 0.6196 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.7884 0.2053 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.4984 0.6217 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.4984 1.4426 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.7838 1.8552 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.0709 1.4446 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.2129 1.8551 0.0000 Br 0 0 0 0 0 0 0 0 0 0 0 0
-0.3579 0.6196 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-1.0724 0.2072 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.0724 -0.6177 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.7822 -1.0294 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.4984 -0.6214 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.2129 -1.0339 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-2.4984 0.2067 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.7841 0.6189 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2 1 2 0
2 3 1 0
3 4 2 0
5 4 1 0
5 6 1 0
6 7 2 0
7 8 1 0
8 9 2 0
9 10 1 0
10 5 2 0
8 11 1 0
4 12 1 0
13 12 1 0
14 13 2 0
14 2 1 0
15 14 1 0
16 15 2 0
16 17 1 0
18 16 1 0
19 18 2 0
13 19 1 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 317.14 | Molecular Weight (Monoisotopic): 315.9735 | AlogP: 3.93 | #Rotatable Bonds: 1 |
Polar Surface Area: 50.44 | Molecular Species: NEUTRAL | HBA: 3 | HBD: 1 |
#RO5 Violations: ┄ | HBA (Lipinski): 3 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 9.14 | CX Basic pKa: ┄ | CX LogP: 3.43 | CX LogD: 3.42 |
Aromatic Rings: 3 | Heavy Atoms: 19 | QED Weighted: 0.74 | Np Likeness Score: 0.52 |
References
1. Kampschulte N, Berking T, Çelik IE, Kirsch SF, Schebb NH.. (2022) Inhibition of cytochrome P450 monooxygenase-catalyzed oxylipin formation by flavonoids: Evaluation of structure-activity relationship towards CYP4F2-selective inhibitors., 238 [PMID:35576701] [10.1016/j.ejmech.2022.114332] |